or Try an Advanced Search...

    Technical Analysis for NRXP - NeuroRx, Inc.

    Grade Last Price % Change Price Change
    F 2.58 5.74% 0.14
    NRXP closed up 5.74 percent on Monday, July 1, 2024, on 16 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NRXP trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 5.74%
    Oversold Stochastic Weakness 5.74%
    Wide Bands Range Expansion -1.53%
    Gapped Up Strength -1.53%
    Oversold Stochastic Weakness -1.53%
    Lower Bollinger Band Walk Weakness 7.05%
    Wide Bands Range Expansion 7.05%
    Below Lower BB Weakness 7.05%
    Older End-of-Day Signals for NRXP ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 9 hours ago
    Up 10% about 9 hours ago
    Up 5% about 9 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    Up 3% about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    NRXP Chart by TradingView
    Basic chart:

    Profile

    NeuroRx, Inc. operates as a clinical stage-small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders. Its drug candidate includes Cyclurad, an oral therapeutic for the treatment of acute/elevated suicidal ideation/crisis in bipolar depression. The company was incorporated in 2015 and is headquartered in Wilmington, Delaware.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Life Sciences Health Sciences Health Care Central Nervous System Disorders Antidepressants Bipolar Disorder Treatment Of Central Nervous System Disorders Atypical Antipsychotics Bipolar Depression

    Is NRXP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing
    Jun 20 NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024
    Jun 18 NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors
    Jun 10 NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter
    May 28 NRx Pharmaceuticals (Nasdaq:NRXP) Presents Landmark Trial of NRX-101 in Suicidal Bipolar Depression At the American Society of Clinical Psychopharmacology Annual Meeting: NRX-101 is the First Oral Antidepressant Demonstrated to Reduce Suicidality in Bi...
    May 15 NRx Pharmaceuticals, Inc. (NRXP) Q1 2024 Earnings Call Transcript
    May 14 NRx Pharmaceuticals reports Q1 results
    May 14 NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update
    May 8 NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update
    May 8 NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024
    See more NRXP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.333
    52 Week Low 1.9
    Average Volume 414,142
    200-Day Moving Average 3.73
    50-Day Moving Average 3.16
    20-Day Moving Average 3.05
    10-Day Moving Average 2.71
    Average True Range 0.31
    RSI (14) 38.27
    ADX 21.28
    +DI 15.11
    -DI 25.18
    Chandelier Exit (Long, 3 ATRs) 3.27
    Chandelier Exit (Short, 3 ATRs) 3.29
    Upper Bollinger Bands 3.86
    Lower Bollinger Band 2.24
    Percent B (%b) 0.21
    BandWidth 53.39
    MACD Line -0.27
    MACD Signal Line -0.21
    MACD Histogram -0.0562
    Fundamentals Value
    Market Cap 219.73 Million
    Num Shares 85.2 Million
    EPS -0.50
    Price-to-Earnings (P/E) Ratio -5.16
    Price-to-Sales 0.00
    Price-to-Book 6.95
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.97
    Resistance 3 (R3) 2.97 2.83 2.91
    Resistance 2 (R2) 2.83 2.73 2.84 2.88
    Resistance 1 (R1) 2.71 2.67 2.77 2.71 2.86
    Pivot Point 2.57 2.57 2.61 2.58 2.57
    Support 1 (S1) 2.45 2.47 2.51 2.45 2.30
    Support 2 (S2) 2.31 2.41 2.32 2.28
    Support 3 (S3) 2.19 2.31 2.26
    Support 4 (S4) 2.19